NCT04633772View on ClinicalTrials.gov

Use of Angiotensin-(1-7) in COVID-19

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions

Infection, CoronavirusRespiratory Failure

Interventions

DRUG

Angiotensin-(1-7)

Intravenous supplementation of Angiotensin-(1-7)

DRUG

Placebo

NaCl 0.9%

Trial Locations (2)

30190-081

Hospital Eduardo de Menezes, Belo Horizonte

31270-910

Hospital Mater Dei, Belo Horizonte

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Federal University of Minas Gerais

OTHER

collaborator

Angitec

UNKNOWN

collaborator

Fonds Erasme pour la Recherche Medicale

UNKNOWN

lead

Erasme University Hospital

OTHER